The SARS-CoV-2 pandemic poses the greatest global public health challenge in a century.
Neutralizing antibody is a correlate of protection and data on kinetics of virus neutralizing …

Background The duration of immunity in SARS-CoV-2 infected people remains unclear.
Neutralizing antibody responses are the best available correlate of protection against re …

High-throughput detection of neutralizing antibodies against SARS-CoV-2 presents a
valuable tool for vaccine trials or investigations of population immunity. We evaluate the …

Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS …

Passive transfer of antibodies from COVID-19 convalescent patients is being used as an
experimental treatment for eligible patients with SARS-CoV-2 infections. The United States …

Virus neutralization assays measure neutralizing antibodies in serum and plasma, and the
plaque reduction neutralization test (PRNT) is considered the gold standard for measuring …

To estimate the seroprevalence and temporal course of SARS-CoV-2 neutralizing
antibodies, we embedded a multi-tiered seroprevalence survey within an ongoing …

Understanding antibody-based SARS-CoV-2 immunity is critical for overcoming the COVID-
19 pandemic and informing vaccination strategies. We evaluated SARS-CoV-2 antibody …

Virus neutralization remains the gold standard for determining antibody efficacy. Therefore,
a high-throughput assay to measure SARS-CoV-2 neutralizing antibodies is urgently …

The protective effect of neutralizing antibodies in SARS-CoV-2 infected individuals is not yet
well defined. To address this issue, we have analyzed the kinetics of neutralizing antibody …